Inmunoterapia para el cáncer de próstata. en China — obtén 3 clínicas con costos

Immunotherapy for prostate cancer in China typically costs from $19,500 to $45,000. Total expenses depend on the specific drug, cycle count, and hospital tier. Patients save around 68% compared to the US, where this treatment costs $102,500 on average. Standard protocol often includes PD-1 inhibitors, oncologist consultations, and initial diagnostic imaging labs.

• Domestic PD-1 inhibitors: $19,500 to $45,000 per cycle using Chinese-manufactured medications.
• Imported drug protocols: Typically cost 70-85% more than domestic versions for Western-made immunotherapy.
• Treatment location: Prices in major hubs like Beijing and Shanghai are often the highest.
• Combination therapy: Adding NK cells or specialized interventional treatments increases the total package price.

Bookimed Expert Insight: Choosing specialized centers in Guangzhou offers a significant value-to-cost ratio. Fuda Cancer Hospital is a prime example, holding JCI accreditation and serving 30,000 international patients. It excels in late-stage cancer care using a combination of immunotherapy and unique technologies like NanoKnife. This integrated approach provides advanced care at a fraction of Western costs.